M&A M&A
Sai Parenterals to acquire majority stake in Bion Therapeutics
Source Bion Therapeutics (opens in a new tab)Press Release (opens in a new tab)
Publicly listed, Hyderabad-based Sai Parenterals is to acquire a majority stake in fellow Hyderabad-based Bion Therapeutics through its wholly owned subsidiary SP Analytics Pvt Ltd in an all-cash deal. The transaction is being executed through SP Analytics, a wholly owned subsidiary of Sai Parenterals.Founded in 2005 by Laxman Prasad Shuklan, Sudesh Raj Mathur and Beerelli Satyam, Bion Therapeutics is a formulations company that provides testing, analysis, and examination services for pharmaceuticals, medicines, drugs, and other materials. The company reported total revenue of INR 47 crore for the financial year 2025-26. For the first half of the current financial year, it recorded revenue of INR 29 crore.